Literature DB >> 35228726

Efficient targeted insertion of large DNA fragments without DNA donors.

Jinlin Wang1,2, Zhou He1,2, Guoquan Wang1,2, Ruiwen Zhang1,2, Junyi Duan1,2, Pan Gao1,2, Xinlin Lei1,2, Houyuan Qiu1,3, Chuanping Zhang1,3, Ying Zhang1,3, Hao Yin4,5,6,7,8,9.   

Abstract

Targeted insertion of large DNA fragments holds great potential for treating genetic diseases. Prime editors can effectively insert short fragments (~44 bp) but not large ones. Here we developed GRAND editing to precisely insert large DNA fragments without DNA donors. In contrast to prime editors, which require reverse transcription templates hybridizing with the target sequence, GRAND editing employs a pair of prime editing guide RNAs, with reverse transcription templates nonhomologous to the target site but complementary to each other. This strategy exhibited an efficiency of up to 63.0% of a 150-bp insertion with minor by-products and 28.4% of a 250-bp insertion. It allowed insertions up to ~1 kb, although the efficiency remains low for fragments larger than 400 bp. We confirmed efficient insertion in multiple genomic loci of several cell lines and non-dividing cells, which expands the scope of genome editing to enable donor-free insertion of large DNA sequences.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35228726     DOI: 10.1038/s41592-022-01399-1

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   47.990


  39 in total

Review 1.  Delivery technologies for genome editing.

Authors:  Hao Yin; Kevin J Kauffman; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2017-03-24       Impact factor: 84.694

Review 2.  Playing the end game: DNA double-strand break repair pathway choice.

Authors:  J Ross Chapman; Martin R G Taylor; Simon J Boulton
Journal:  Mol Cell       Date:  2012-08-24       Impact factor: 17.970

Review 3.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

4.  Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.

Authors:  Keiichiro Suzuki; Mako Yamamoto; Reyna Hernandez-Benitez; Zhe Li; Christopher Wei; Rupa Devi Soligalla; Emi Aizawa; Fumiyuki Hatanaka; Masakazu Kurita; Pradeep Reddy; Alejandro Ocampo; Tomoaki Hishida; Masahiro Sakurai; Amy N Nemeth; Estrella Nuñez Delicado; Josep M Campistol; Pierre Magistretti; Pedro Guillen; Concepcion Rodriguez Esteban; Jianhui Gong; Yilin Yuan; Ying Gu; Guang-Hui Liu; Carlos López-Otín; Jun Wu; Kun Zhang; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2019-08-23       Impact factor: 25.617

5.  In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.

Authors:  Keiichiro Suzuki; Yuji Tsunekawa; Reyna Hernandez-Benitez; Jun Wu; Jie Zhu; Euiseok J Kim; Fumiyuki Hatanaka; Mako Yamamoto; Toshikazu Araoka; Zhe Li; Masakazu Kurita; Tomoaki Hishida; Mo Li; Emi Aizawa; Shicheng Guo; Song Chen; April Goebl; Rupa Devi Soligalla; Jing Qu; Tingshuai Jiang; Xin Fu; Maryam Jafari; Concepcion Rodriguez Esteban; W Travis Berggren; Jeronimo Lajara; Estrella Nuñez-Delicado; Pedro Guillen; Josep M Campistol; Fumio Matsuzaki; Guang-Hui Liu; Pierre Magistretti; Kun Zhang; Edward M Callaway; Kang Zhang; Juan Carlos Izpisua Belmonte
Journal:  Nature       Date:  2016-11-16       Impact factor: 49.962

Review 6.  Strategies for In Vivo Genome Editing in Nondividing Cells.

Authors:  Fatemeharefeh Nami; Mohsen Basiri; Leila Satarian; Cameron Curtiss; Hossein Baharvand; Catherine Verfaillie
Journal:  Trends Biotechnol       Date:  2018-04-21       Impact factor: 19.536

Review 7.  Therapeutic genome editing: prospects and challenges.

Authors:  David Benjamin Turitz Cox; Randall Jeffrey Platt; Feng Zhang
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

8.  A mechanism for the suppression of homologous recombination in G1 cells.

Authors:  Alexandre Orthwein; Sylvie M Noordermeer; Marcus D Wilson; Sébastien Landry; Radoslav I Enchev; Alana Sherker; Meagan Munro; Jordan Pinder; Jayme Salsman; Graham Dellaire; Bing Xia; Matthias Peter; Daniel Durocher
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

9.  Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining.

Authors:  Marcello Maresca; Victor Guosheng Lin; Ning Guo; Yi Yang
Journal:  Genome Res       Date:  2012-11-14       Impact factor: 9.043

10.  ClinVar: public archive of relationships among sequence variation and human phenotype.

Authors:  Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  3 in total

Review 1.  Gene Editing in Human Haematopoietic Stem Cells for the Treatment of Primary Immunodeficiencies.

Authors:  Sameer Bahal; Klesti Karaxhuku; Giorgia Santilli
Journal:  Mol Diagn Ther       Date:  2022-10-14       Impact factor: 4.476

Review 2.  Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases.

Authors:  Yaoyao Lu; Cedric Happi Mbakam; Bo Song; Eli Bendavid; Jacques-P Tremblay
Journal:  Front Genome Ed       Date:  2022-07-26

Review 3.  Precise somatic genome editing for treatment of inborn errors of immunity.

Authors:  Qingzhou Meng; Haixiang Sun; Jianghuai Liu
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.